WELL Health Technologies Corp. (WHTCF)
USD 4.99
(1.88%)
USD 4.99
(1.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 91.32 Million CAD | 31.78% |
| 2022 | 77.3 Million CAD | 141.53% |
| 2021 | 32 Million CAD | 668.92% |
| 2020 | -5.62 Million CAD | -62.96% |
| 2019 | -4.15 Million CAD | -74.45% |
| 2018 | -1.97 Million CAD | -118.45% |
| 2017 | - CAD | -58.15% |
| 2016 | -147.75 Thousand CAD | -1362.62% |
| 2015 | -39.16 Thousand CAD | -11.4% |
| 2014 | -35.15 Thousand CAD | 70.05% |
| 2013 | -117.39 Thousand CAD | -112.6% |
| 2012 | -53.54 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 29.14 Million CAD | 59.08% |
| 2024 Q2 | 31.43 Million CAD | 7.87% |
| 2023 Q1 | 22.24 Million CAD | 48.18% |
| 2023 FY | - CAD | 31.78% |
| 2023 Q4 | 28.87 Million CAD | 39.68% |
| 2023 Q3 | 20.66 Million CAD | -4.47% |
| 2023 Q2 | 21.63 Million CAD | -2.74% |
| 2022 Q3 | 30.56 Million CAD | 56.98% |
| 2022 Q2 | 19.46 Million CAD | -0.74% |
| 2022 Q1 | 19.61 Million CAD | 17.96% |
| 2022 FY | - CAD | 141.53% |
| 2022 Q4 | 15.01 Million CAD | -50.88% |
| 2021 Q2 | 6.29 Million CAD | 263.34% |
| 2021 Q3 | 12.93 Million CAD | 105.64% |
| 2021 Q4 | 16.62 Million CAD | 28.51% |
| 2021 FY | - CAD | 668.92% |
| 2021 Q1 | -3.85 Million CAD | -69.51% |
| 2020 Q2 | -1.21 Million CAD | -172.81% |
| 2020 Q4 | -2.27 Million CAD | -33.77% |
| 2020 Q3 | -1.69 Million CAD | -40.28% |
| 2020 Q1 | -443.88 Thousand CAD | 40.01% |
| 2020 FY | - CAD | -62.96% |
| 2019 FY | - CAD | -74.45% |
| 2019 Q1 | -684.31 Thousand CAD | 0.0% |
| 2019 Q2 | -822.62 Thousand CAD | -20.21% |
| 2019 Q3 | -1.2 Million CAD | -46.55% |
| 2019 Q4 | -739.95 Thousand CAD | 38.62% |
| 2018 Q3 | -897.1 Thousand CAD | -48.76% |
| 2018 FY | - CAD | -118.45% |
| 2018 Q2 | -603.05 Thousand CAD | -363.85% |
| 2018 Q1 | -130.01 Thousand CAD | 68.26% |
| 2017 Q2 | -417.83 Thousand CAD | -138.85% |
| 2017 Q3 | -4.88 Million CAD | -1069.04% |
| 2017 Q4 | -409.62 Thousand CAD | 91.61% |
| 2017 Q1 | -174.93 Thousand CAD | -172.9% |
| 2017 FY | - CAD | -58.15% |
| 2016 Q1 | -254.96 Thousand CAD | -722.33% |
| 2016 Q3 | -153.21 Thousand CAD | -14.64% |
| 2016 FY | - CAD | -1362.62% |
| 2016 Q4 | -64.1 Thousand CAD | 58.16% |
| 2016 Q2 | -133.64 Thousand CAD | 47.58% |
| 2015 Q4 | -31 Thousand CAD | -817.58% |
| 2015 Q2 | -9102.00 CAD | 55.84% |
| 2015 Q1 | -20.61 Thousand CAD | 81.62% |
| 2015 FY | - CAD | -11.4% |
| 2015 Q3 | -3379.00 CAD | 62.88% |
| 2014 Q1 | -15.78 Thousand CAD | -99.91% |
| 2014 Q3 | -9076.00 CAD | -278.8% |
| 2014 Q4 | -112.11 Thousand CAD | -1135.27% |
| 2014 FY | - CAD | 70.05% |
| 2014 Q2 | -2396.00 CAD | 84.82% |
| 2013 Q4 | -7897.00 CAD | 72.95% |
| 2013 Q3 | -29.19 Thousand CAD | 43.11% |
| 2013 Q2 | -51.31 Thousand CAD | -44.08% |
| 2013 Q1 | -35.61 Thousand CAD | -1238.95% |
| 2013 FY | - CAD | -112.6% |
| 2012 Q3 | -46.44 Thousand CAD | -1435.34% |
| 2012 Q2 | -3025.00 CAD | 75.91% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | -12.55 Thousand CAD | -353.39% |
| 2012 Q4 | -2660.00 CAD | 94.27% |
| 2011 Q1 | -63.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 100.0% |
| 2011 Q4 | -2770.00 CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 931.483% |
| Arem Pacific Corporation | 36.71 Thousand USD | -248643.021% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 80983.173% |
| BioCorRx Inc. | -2.68 Million USD | 3502.707% |
| Bionik Laboratories Corp. | -4.77 Million USD | 2012.301% |
| Banyan Corp. | 583.94 Thousand USD | -15539.567% |
| Clearday, Inc. | -7.53 Million USD | 1311.801% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -709338.359% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 8491.782% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 4232.793% |
| Selectis Health, Inc. | -7.29 Million USD | 1352.033% |
| Ethema Health Corporation | 2.07 Million USD | -4307.26% |
| HealthLynked Corp. | -2.75 Million USD | 3420.577% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 3540.568% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -316498.489% |
| Comjoyful International Company | 167.89 Thousand USD | -54294.711% |
| Medical Facilities Corporation | 77.94 Million USD | -17.167% |
| MedSmart Group Inc. | 47.8 Thousand USD | -190922.611% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 14751.308% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -9083.43% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 45371.402% |
| PAO Group, Inc. | 292.96 Thousand USD | -31073.22% |
| Primemd Inc. | 3.42 Million USD | -2564.942% |
| Raffles Medical Group Ltd | 100.7 Million USD | 9.309% |
| Ryman Healthcare Limited | -54.51 Million USD | 267.517% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 2157576.967% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 3255.431% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 16540.117% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 186479.592% |
| Veltex Corporation | -938.45 Thousand USD | 9831.506% |
| World Financial Holding Group | -28.43 Thousand USD | 321331.094% |
| Xcelerate Inc. | -2.53 Million USD | 3697.858% |